|
Top search choices8. Floaters 9. Optic Nerve 12. Vision Rehabilitation of Infants
Hot Topics Hot Topics:
Smoking Linked to Macular Degeneration
Vitamin E and Macular Degeneration
AREDS2 Nutritional Study for AMD
|
_________________ AREDS2 StudyImportant: Patients are now being enrolled in the AREDS2 study for AMD (Age-related Macular Degeneration). This is a real, NIH supported clinical trial that will define care for AMD patients for the next decade. This is a nutritional study about taking by mouth nutritional supplements. The supplements are "macular xanthophylls (lutein and zeaxanthin) and/or long-chain omega-3 fatty acids (docosahexaenoic acid) [DHA] and eicosapentaenoic acid [EPA] )...and to assess whether forms of the AREDS nutritional supplement with reduced zinc and/or no beta-carotene work as well as the original supplement in reducing the risk of progression to advanced AMD..." Here is your chance to help your eye sight (or your mother's or father's) and contribute to real science. If you have AMD or have a close one that does, do the following: See if there is a participating center in your area at the following web address (but don't forget where you heard this (OhioLionsEyeResearch.com):
Visit the web site for the AREDS2 study for more information: We are providing this information as a public service to the ones we, as LIONS members, support, both in terms of services (e.g., pilot dogs, LIONS eye bank, Central Ohio Reading Service for the Blind) and research dollars. The Lion Web Master (Lion Larry) just sent this info to PDG Lion Dick N........... Good Luck in Lionism. "The Age-Related Eye Disease Study II (AREDS2) is a multi-center, randomized trial designed to assess the effects of oral supplementation of macular xanthophylls (lutein and zeaxanthin) and/or long-chain omega-3 fatty acids (docosahexaenoic acid) [DHA] and eicosapentaenoic acid [EPA] ) on the progression to advanced age-related macular degeneration (AMD). An additional goal of the study is to assess whether forms of the AREDS nutritional supplement with reduced zinc and/or no beta-carotene works as well as the original supplement in reducing the risk of progression to advanced AMD." - from http://www.areds2.org/
|
|